MD
Matthew Vincent Dolan (EVP, Strategy & Corporate Dev) filed 1 Form 4 report in the past 24 months (0 purchases, 1 sale), most often in DexCom, Inc. (DXCM). The largest single filing was $103K of DXCM (1,183 sh × $86.91, as filed), executed Jan 29 2025. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$103K
shares × price, as filed
Last traded
Jan 29 2025
Filed Jan 30 2025
Median ADV $483.2M across their filed names
Open performance→Volume by month
Buys $0
Sells $103K
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 24 months
Most traded names
DXCMRecent filings
DXCMSALE
DexCom, Inc.
View filing →
$103K1,183 sh × $86.91
Exec Jan 29 2025
Filed Jan 30 2025 · 5:30 PM ET